NDC 0713-0805

TAZAROTENE

Tazarotene

TAZAROTENE is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is Tazarotene.

Product ID0713-0805_e8b5c6ef-1d65-446a-e053-2995a90a1f48
NDC0713-0805
Product TypeHuman Prescription Drug
Proprietary NameTAZAROTENE
Generic NameTazarotene
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2022-09-14
Marketing CategoryANDA /
Application NumberANDA215433
Labeler NameCosette Pharmaceuticals, Inc.
Substance NameTAZAROTENE
Active Ingredient Strength1 mg/g
Pharm ClassesRetinoid [EPC], Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0713-0805-31

1 TUBE in 1 CARTON (0713-0805-31) > 30 g in 1 TUBE
Marketing Start Date2022-09-14
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "TAZAROTENE" or generic name "Tazarotene"

NDCBrand NameGeneric Name
0168-0454TAZAROTENEtazarotene
0713-0670TazaroteneTazarotene
0713-0764TazaroteneTazarotene
0713-0804TAZAROTENEtazarotene
0713-0805TAZAROTENEtazarotene
51672-1373TazaroteneTazarotene
51672-1374TazaroteneTazarotene
60758-556TazaroteneTazarotene
60758-561TazaroteneTazarotene
68308-685tazarotenetazarotene
68308-745TazaroteneTAZAROTENE
0187-2098Arazlotazarotene
0023-9236AVAGEtazarotene
51862-295FABIORtazarotene
0168-0455Tazarotene Creamtazarotene
0023-0042TAZORACtazarotene
0023-8335TAZORACtazarotene
0023-9155TAZORACtazarotene
0023-9156TAZORACtazarotene
16110-042Tazoractazarotene
16110-833Tazoractazarotene
16110-915TAZORACtazarotene
16110-916TAZORACtazarotene

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.